Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,Hematology
Reference57 articles.
1. Ridge CA, Pua BB, Madoff DC: Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol 2014;31:3-8.
2. Gandaglia G, Ravi P, Abdollah F, et al.: Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J 2014;8:247-252.
3. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM: The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs - Part A: Renal, Penile, and Testicular Tumours. Eur Urol 2016;70:93-105.
4. Marchioni M, Preisser F, Bandini M, et al.: Comparison of partial versus radical nephrectomy effect on other-cause mortality, cancer-specific mortality, and 30-day mortality in patients older than 75 years. Eur Urol Focus 2018;Epub ahead of print.
5. Gill DM, Hahn AW, Hale P, Maughan BL: Overview of current and future first-line systemic therapy for metastatic clear cell renal cell carcinoma. Curr Treat Options Oncol 2018;19:6.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in non‐clear cell renal cell carcinoma management: From heterogeneous biology to treatment options;International Journal of Cancer;2023-10-12
2. The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma;Frontiers in Oncology;2023-10-02
3. Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808;Clinical Genitourinary Cancer;2023-10
4. Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience;Cancers;2023-08-31
5. Interdisziplinäre Empfehlungen zur Behandlung des fortgeschrittenen Nierenzellkarzinoms;TumorDiagnostik & Therapie;2023-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3